TNF and inflammatory bowel disease: Sehdev et al. [31] reported a 16-year-old boy with Crohn’s disease (inflammatory bowel disease), in remission with anti-tumor necrosis factor (TNF) treatment (adalimumab), who presented with acute-on-chronic bilateral lower extremity pain, initially attributed to an overuse injury post-Junior Olympics participation.